Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers
Medical Science Monitor(2023)
Key words
Breast Neoplasms,Receptor,ErbB-2,Neoplasm Metastasis,Antineoplastic Agents,Survival,Costs and Cost Analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined